This website is intended for healthcare professionals only.

Hospital Healthcare Europe
Hospital Pharmacy Europe     Newsletter       

Oncology

18
Sacituzumab govitecan gains EU approval for HR+/HER2- breast cancer
Sacituzumab govitecan gains EU approval for HR+/HER2- breast cancer
Read more
Reinforcement learning AI model improves accuracy of skin cancer diagnoses
Reinforcement learning AI model improves accuracy of skin cancer diagnoses
Read more
Plasma ctDNA testing reduces time to treatment in advanced lung cancer
Plasma ctDNA testing reduces time to treatment in advanced lung cancer
Read more
Novel MOv18 IgE antibody shows potential as ovarian cancer therapy
Novel MOv18 IgE antibody shows potential as ovarian cancer therapy
Read more
Women treated for breast cancer show signs of accelerated biological ageing
Women treated for breast cancer show signs of accelerated biological ageing
Read more
Does occupation really affect ovarian cancer risk?
Does occupation really affect ovarian cancer risk?
Read more
Is two years enough for immune checkpoint inhibitor therapy in non-small cell lung cancer?
Is two years enough for immune checkpoint inhibitor therapy in non-small cell lung cancer?
Read more
Novel oral cancer survival calculator includes comorbidities to offer more accurate estimates
Novel oral cancer survival calculator includes comorbidities to offer more accurate estimates
Read more
High tumour monocyte content linked to improved survival in oesophageal cancer
High tumour monocyte content linked to improved survival in oesophageal cancer
Read more
Potential for faecal microbiota transplantation to enhance immunotherapy in advanced melanoma
Potential for faecal microbiota transplantation to enhance immunotherapy in advanced melanoma
Read more
Persistent CD19 CAR T-cells may explain longer remission for children with relapsed leukaemia
Persistent CD19 CAR T-cells may explain longer remission for children with relapsed leukaemia
Read more
Melanoma in situ and mortality: is there cause for concern?
Melanoma in situ and mortality: is there cause for concern?
Read more
Cyclophosphamide regime reduces graft-versus-host disease after stem-cell transplantation 
Cyclophosphamide regime reduces graft-versus-host disease after stem-cell transplantation 
Read more
England’s first-ever lung cancer screening programme to see national rollout
England’s first-ever lung cancer screening programme to see national rollout
Read more
Perioperative pembrolizumab improves event-free survival in early-stage lung cancer
Perioperative pembrolizumab improves event-free survival in early-stage lung cancer
Read more
Base-edited CAR7 T cells a potential treatment for relapsed T-cell leukaemia
Base-edited CAR7 T cells a potential treatment for relapsed T-cell leukaemia
Read more
Vorasidenib found to improve progression-free survival in IDH–mutant grade 2 gliomas
Vorasidenib found to improve progression-free survival in IDH–mutant grade 2 gliomas
Read more
Selinexor triple therapy improves survival in lenalidomide-refractory multiple myeloma
Selinexor triple therapy improves survival in lenalidomide-refractory multiple myeloma
Read more

Popular articles

Diagnostic delays and reduced DMARD therapy identified in psoriatic arthritis
Overcoming the reluctance to prescribe anticoagulants in older people with AF
Is revascularisation needed for stroke prevention in all patients with carotid stenosis?
Smoking may not explain disparity in COPD rates between sexes, study suggests
NICE withdraws Covid-19 antiviral eligibility for some at-risk groups



 
FOLLOW US

IMPORTANT LINKS

MORE FROM COGORA

© Cogora 2025
Cogora Limited. 1 Giltspur Street, London EC1A 9DD Registered in the United Kingdom. Reg. No. 2147432

Cogora
x